Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Authors
Keywords
Adaptive immune response, Immune checkpoint inhibitors, Immunotherapy, Tumor microenvironment, Matrix remodeling, Immune biomarkers
Journal
Journal for ImmunoTherapy of Cancer
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-03
DOI
10.1186/s40425-018-0376-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
- (2018) Michael B Atkins et al. LANCET ONCOLOGY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Tumor-associated macrophages: from basic research to clinical application
- (2017) Li Yang et al. Journal of Hematology & Oncology
- Versican-Derived Matrikines Regulate Batf3–Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer
- (2017) Chelsea Hope et al. JOURNAL OF IMMUNOLOGY
- Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche
- (2017) Fotis Asimakopoulos et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade
- (2017) Xuyang Wen et al. ONCOLOGY RESEARCH
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- Development, Diversity, and Function of Dendritic Cells in Mouse and Human
- (2017) David A. Anderson et al. Cold Spring Harbor Perspectives in Biology
- Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
- (2017) Oliver M.T. Pearce et al. Cancer Discovery
- Endothelial Basement Membrane Laminin 511 Contributes to Endothelial Junctional Tightness and Thereby Inhibits Leukocyte Transmigration
- (2017) Jian Song et al. Cell Reports
- Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
- (2017) Thomas Powles et al. JAMA Oncology
- Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review
- (2017) Charissa A. C. Jessurun et al. Frontiers in Oncology
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma
- (2017) Alexandre Reuben et al. npj Genomic Medicine
- Indicators of responsiveness to immune checkpoint inhibitors
- (2017) Bradley D. Shields et al. Scientific Reports
- Immunoregulatory roles of versican proteolysis in the myeloma microenvironment
- (2016) C. Hope et al. BLOOD
- Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?
- (2016) Deborah Mukherji et al. Clinical Genitourinary Cancer
- PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
- (2016) Ashley Cimino-Mathews et al. HUMAN PATHOLOGY
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
- (2016) Weijie Ma et al. Journal of Hematology & Oncology
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
- (2016) Andrea Botticelli et al. Oncotarget
- Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer
- (2016) Yusuke Inoue et al. Oncotarget
- Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
- (2016) Zachary A. Cooper et al. OncoImmunology
- Insight On Colorectal Carcinoma Infiltration by Studying Perilesional Extracellular Matrix
- (2016) Manuela Nebuloni et al. Scientific Reports
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
- (2015) Dalil Hannani et al. CELL RESEARCH
- Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
- (2015) J. M. Taube et al. CLINICAL CANCER RESEARCH
- The regulation of immune cell trafficking by the extracellular matrix
- (2015) Rupert Hallmann et al. CURRENT OPINION IN CELL BIOLOGY
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ADAMTS proteases and cancer
- (2015) Santiago Cal et al. MATRIX BIOLOGY
- Moving targets: Emerging roles for MMPs in cancer progression and metastasis
- (2015) Gemma Shay et al. MATRIX BIOLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
- (2015) Rafael Carretero et al. NATURE IMMUNOLOGY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prognostic significance of PD-L1 in bladder cancer
- (2015) YIDE HUANG et al. ONCOLOGY REPORTS
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling
- (2015) Michael Tang et al. Cell Reports
- The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family
- (2015) Richard Kelwick et al. GENOME BIOLOGY
- Prognostic significance of Versican expression in gastric adenocarcinoma
- (2015) X-H Shen et al. Oncogenesis
- Cancer Microenvironment and Inflammation: Role of Hyaluronan
- (2015) Dragana Nikitovic et al. Frontiers in Immunology
- Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
- (2015) Giovanni Francesco Castino et al. OncoImmunology
- Association of Somatic Mutations ofADAMTSGenes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma
- (2015) Yuexin Liu et al. JAMA Oncology
- Versican and the regulation of cell phenotype in disease
- (2014) Thomas N. Wight et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
- (2014) K. A. Schalper et al. CLINICAL CANCER RESEARCH
- Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
- (2014) Jia Xue et al. IMMUNITY
- Laminins affect T cell trafficking and allograft fate
- (2014) Kristi J. Warren et al. JOURNAL OF CLINICAL INVESTIGATION
- Versican and the control of inflammation
- (2014) Thomas N. Wight et al. MATRIX BIOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cells
- (2014) C.-M. Horejs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses
- (2014) Emmanuelle Godefroy et al. Cell Reports
- Myeloid-derived cells are key targets of tumor immunotherapy
- (2014) José Medina-Echeverz et al. OncoImmunology
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- TGF-β Activation and Function in Immunity
- (2013) Mark A. Travis et al. Annual Review of Immunology
- Melanoma-Educated CD14 + Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
- (2013) Yumeng Mao et al. CANCER RESEARCH
- Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
- (2013) J. Goc et al. CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Myeloid-derived suppressor cells in cancer: recent progress and prospects
- (2013) Yazan S Khaled et al. IMMUNOLOGY AND CELL BIOLOGY
- Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force
- (2013) Katarina Wolf et al. JOURNAL OF CELL BIOLOGY
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
- (2013) David Vasquez-Dunddel et al. JOURNAL OF CLINICAL INVESTIGATION
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-Derived Vascular Pericytes Anergize Th Cells
- (2013) A. Bose et al. JOURNAL OF IMMUNOLOGY
- Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma
- (2013) Katharina Ochs et al. JOURNAL OF NEUROIMMUNOLOGY
- Programmed death ligand-1 expression in non-small cell lung cancer
- (2013) Vamsidhar Velcheti et al. LABORATORY INVESTIGATION
- Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model
- (2013) Wenxiu Zhao et al. LABORATORY INVESTIGATION
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laminin-511
- (2013) Normand Pouliot et al. Cell Adhesion & Migration
- PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
- (2013) E. J. Lipson et al. Cancer Immunology Research
- Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition
- (2012) D. Gao et al. CANCER RESEARCH
- VEGFA-VEGFR Pathway Blockade Inhibits Tumor-Induced Regulatory T-cell Proliferation in Colorectal Cancer
- (2012) M. Terme et al. CANCER RESEARCH
- Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA
- (2012) Simon Toupance et al. CLINICAL & EXPERIMENTAL METASTASIS
- Glycosaminoglycans: key players in cancer cell biology and treatment
- (2012) Nikos Afratis et al. FEBS Journal
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- Inflammation Amplification by Versican: The First Mediator
- (2012) Zhenwei Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration
- (2012) Neveen Said et al. JOURNAL OF CLINICAL INVESTIGATION
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
- (2012) Hélène Salmon et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity
- (2012) S. J. Saleem et al. JOURNAL OF IMMUNOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- CXCL17 Expression by Tumor Cells Recruits CD11b+Gr1highF4/80− Cells and Promotes Tumor Progression
- (2012) Aya Matsui et al. PLoS One
- Role of TLR2-dependent inflammation in metastatic progression
- (2011) Sunhwa Kim et al. Annals of the New York Academy of Sciences
- Polarization of Tumor-Associated Macrophages: A Novel Strategy for Vascular Normalization and Antitumor Immunity
- (2011) Yuhui Huang et al. CANCER CELL
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 Mediates the Transmigration of Regulatory T Cells across Human Hepatic Sinusoidal Endothelium
- (2011) Shishir Shetty et al. JOURNAL OF IMMUNOLOGY
- Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration
- (2011) Stephen P. Evanko et al. MATRIX BIOLOGY
- The Matrisome:In SilicoDefinition andIn VivoCharacterization by Proteomics of Normal and Tumor Extracellular Matrices
- (2011) Alexandra Naba et al. MOLECULAR & CELLULAR PROTEOMICS
- Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1
- (2011) Tomasz P. Rygiel et al. MOLECULAR IMMUNOLOGY
- High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation
- (2011) Anu S. Maharjan et al. PLoS One
- Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
- (2011) R. O. Hynes et al. Cold Spring Harbor Perspectives in Biology
- Heparan Sulfate Proteoglycans
- (2011) S. Sarrazin et al. Cold Spring Harbor Perspectives in Biology
- The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
- (2010) Keith Brew et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients
- (2010) Olivier Adotevi et al. JOURNAL OF IMMUNOTHERAPY
- Role of Lymphatic Vessels in Tumor Immunity: Passive Conduits or Active Participants?
- (2010) Amanda W. Lund et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer
- (2010) Arko Gorter et al. MODERN PATHOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model
- (2010) Zhuoshun Yang et al. PLoS One
- In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction
- (2010) N. R. Blatner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The biological role and regulation of versican levels in cancer
- (2009) Carmela Ricciardelli et al. CANCER AND METASTASIS REVIEWS
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response
- (2009) Laura Alaniz et al. CANCER LETTERS
- Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
- (2009) P.-Y. Pan et al. CANCER RESEARCH
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer
- (2009) Kristen M. Drescher et al. Familial Cancer
- PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells
- (2009) Wenshi Wang et al. INTERNATIONAL IMMUNOLOGY
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells
- (2009) Paul L. Bollyky et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- The Extracellular Matrix: Not Just Pretty Fibrils
- (2009) R. O. Hynes SCIENCE
- The matricellular functions of small leucine-rich proteoglycans (SLRPs)
- (2009) Rosetta Merline et al. Journal of Cell Communication and Signaling
- In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor- 1
- (2008) J. Ahamed et al. BLOOD
- Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature
- (2008) P. C. Maciag et al. CANCER RESEARCH
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
- Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures
- (2008) Marie-Caroline Dieu-Nosjean et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid leukocyte migration by integrin-independent flowing and squeezing
- (2008) Tim Lämmermann et al. NATURE
- CTLA-4 blockade increases IFN -producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
- (2008) C. I. Liakou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started